The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

Turning to the acquired business contribution, following today's expected close of the transaction, we expect the Biosciences ...

The successful clinical validation of AlloHeme represents a key milestone in CareDx's Transplant+ strategy, expanding the Company's precision medicine capabilities into cell therapy, hematology, and ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed spin-off of its Biosciences & Diagnostic business, followed by the merger of ...

In children with stage 1 type 1 diabetes, high daily doses of oral insulin for 1 year do not halt progression to dysglycemia or clinical diabetes, nor do they affect insulin autoantibody levels.